Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT FOR PERIOD ENDED JUNE 30, 2010 - Pure Pharmaceuticals CORP | form10q.htm |
| EX-31.1 - CERTIFICATION - Pure Pharmaceuticals CORP | exhibit31-1.htm |
| EX-32.1 - CERTIFICATION - Pure Pharmaceuticals CORP | exhibit32-1.htm |
| EX-31.2 - CERTIFICATION - Pure Pharmaceuticals CORP | exhibit31-2.htm |
EXHIBIT 32.2
| CERTIFICATION PURSUANT TO |
| 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO |
| SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 |
The undersigned, Charlie Lee, Chief Financial Officer and Principal Accounting Officer of Pure Pharmaceuticals Corp. (the “Company”), hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) |
the quarterly report on Form 10-Q of the Company for the period ended June 30, 2010 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
| (2) |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: August 23, 2010
/s/ Charlie Lee
Charlie Lee
Chief Financial
Officer and Principal Accounting Officer